DIMA Biotechnology LTD is a research and development company of recombinant monoclonal antibody focusing on immune oncology products and services. DIMA’s proprietary B cell cloning and recombinant monoclonal antibody development platform, DimAb®, can efficiently generate high-quality monoclonal antibodies in high throughput. The R&D team has many years of experience in monoclonal antibody development. We provide solutions for scientific research, clinical diagnosis and therapeutic R&D.
The corporate culture is integrity, pragmatism, innovation and focus. The mission for the company is to apply advanced biotechnology to provide new and effective solutions for cancer diagnosis and treatment.
Company Details
- Address
- No. 8, Jinfeng Road, High Tech Zone,, Room 411-6,building 2,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.dimabio.com/
- Keywords
- Consumer Services.
- HQ
- Suzhou, Jiangsu
Dima Biotechnology Ltd Questions
Dima Biotechnology Ltd's website is http://www.dimabio.com/
Dima Biotechnology Ltd's LinkedIn profile is https://cn.linkedin.com/company/dima-biotechnology-ltd
Dima Biotechnology Ltd's industry is
Biotechnology Research
Dima Biotechnology Ltd's top competitors are
Laboratory Corporation Of America Holdings,
Symcell,
American Society For Artificial Internal Organs,
Aashvi Proficiency Testing & Analytical Services,
Absolute Standards Inc,
Tauc3 Biologics,
Phenova,
Cancer Advances, Inc.,
Prodigest Academy,
Chem By Cell Press.
Dima Biotechnology Ltd's categories are Biotechnology Research
